Avantor (AVTR) Scheduled to Post Quarterly Earnings on Friday

Avantor (NYSE:AVTR) is set to release its earnings data before the market opens on Friday, April 26th. Analysts expect Avantor to post earnings of $0.20 per share for the quarter. Avantor has set its FY 2024 guidance at 0.960-1.040 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.22 by $0.03. The firm had revenue of $1.72 billion during the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The company’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.32 earnings per share. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Avantor Stock Down 0.4 %

NYSE AVTR opened at $24.29 on Friday. Avantor has a 1 year low of $16.63 and a 1 year high of $26.16. The stock has a market capitalization of $16.48 billion, a PE ratio of 50.60, a PEG ratio of 1.55 and a beta of 1.37. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.05. The business’s 50-day moving average is $24.91 and its 200 day moving average is $22.44.

Wall Street Analysts Forecast Growth

AVTR has been the subject of several research reports. Evercore ISI upped their price objective on shares of Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. UBS Group raised their price objective on shares of Avantor from $25.00 to $29.00 and gave the stock a “buy” rating in a report on Thursday, February 15th. Deutsche Bank Aktiengesellschaft lifted their price objective on Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research report on Thursday. Citigroup increased their target price on Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Finally, Robert W. Baird lifted their price target on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Thursday, February 15th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $26.71.

Insider Activity at Avantor

In other Avantor news, EVP James Bramwell sold 6,203 shares of the stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares in the company, valued at $2,476,992.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.50% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Avantor

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Quarry LP bought a new position in shares of Avantor during the fourth quarter worth $30,000. Groupama Asset Managment purchased a new position in shares of Avantor during the fourth quarter valued at about $91,000. UniSuper Management Pty Ltd bought a new stake in shares of Avantor in the second quarter worth about $99,000. Systematic Financial Management LP purchased a new stake in shares of Avantor in the first quarter worth about $168,000. Finally, Covestor Ltd boosted its stake in Avantor by 201.9% during the first quarter. Covestor Ltd now owns 5,250 shares of the company’s stock valued at $178,000 after buying an additional 3,511 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.